Treatment for Squamous Cell Carcinoma

Indiana University Melvin & Bren Simon Cancer Center, Indianapolis, IN
Squamous Cell Carcinoma+2 More Conditions
All Sexes
What conditions do you have?

Study Summary

This trial will test if SLNB can help find tumors in patients with node-negative cutaneous squamous cell carcinoma of the head or neck.

Eligible Conditions
  • Skin Squamous Cell Carcinoma
  • Skin Cancer
  • Squamous Cell Carcinoma

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Baseline to 1 year

Incidence of metastasis
Baseline to 1 year
Evaluate the gene profile of tumor
Evaluate the gene profile via validated 40-gene expression profile (40-GEP) to identify common mutations associated with high-risk tumors characteristics.
Evaluate the tumor variables

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

0 Treatment Group

94 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 1 year

Who is running the clinical trial?

Indiana UniversityLead Sponsor
910 Previous Clinical Trials
775,907 Total Patients Enrolled
Jessica Yesensky, MDPrincipal InvestigatorIndiana University

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What is the participant quota for this clinical trial?

"Affirmative. data demonstrate that this investigation is currently recruiting test subjects. This research project, which was first published on October 25th 2021, seeks 94 volunteers from a single medical facility." - Anonymous Online Contributor

Unverified Answer

Are there any vacancies for potential volunteers in this trial?

"Affirmative. The clinical trial details hosted on verify that this medical study, first posted on October 25th 2021, is presently recruiting patients. 94 participants need to be sourced from a single clinic location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.